drugset / Trial / NCT00518765

Hemodynamic Effects of Aliskiren Compared to Captopril on the Kidney in Healthy Volunteers on a Low- and High- Sodium Diet

NCT00518765

Phase 3 Completed 32 enrolled Novartis
RandomizedCrossoverSingle-blindBasic science

Summary

This study will measure the effects of different doses of aliskiren on kidney blood flow and function in healthy adults and determine how salt intake affects the response to aliskiren.

Timeline

Start
2005-10
Primary completion
2007-08
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Aliskiren Small molecule 600 mg Oral

Indications